Alexandria Real Estate Equities reported a net loss per share of $0.96 and FFO per share, as adjusted, of $2.05 for the first quarter of 2022. The company continued to experience strong leasing volume and internal growth.
Total revenues reached $615.1 million, a 28.2% increase year-over-year.
The company executed long-term leases, including 426,927 RSF with Bristol-Myers Squibb and 333,929 RSF with Eli Lilly and Company.
Net operating income (cash basis) annualized reached $1.5 billion, up 24.9% compared to 1Q21 annualized.
Liquidity stood at $5.7 billion as of March 31, 2022.
The following updated guidance is based on our current view of existing market conditions and assumptions for the year ending December 31, 2022.